Keezio Group v. Regeneron Pharmaceuticals: Design Patent Dispute Ends in Voluntary Dismissal

📄 View Full Report 📥 Export PDF 🔗 Share ⭐ Save

📋 Case Summary

Case NameKeezio Group, LLC v. Regeneron Pharmaceuticals, Inc.
Case Number5:24-cv-00284
CourtU.S. District Court for the Northern District of California
DurationJan 17, 2024 – Mar 11, 2024 54 days
OutcomePlaintiff Withdrawal — Voluntary Dismissal Without Prejudice
Patents at Issue
Accused ProductsRegalo Inflatable Toddler Travel Bed with 4-Sided Bed Bumpers and Handles

Case Overview

The Parties

⚖️ Plaintiff

A consumer products intellectual property holding entity with a focus on asserting design and utility patent rights in juvenile and household product categories.

🛡️ Defendant

Globally recognized biopharmaceutical company. The actual dismissal notice named Regalo International, LLC, suggesting a potential clerical or docketing discrepancy in the original filing.

The Patent at Issue

The asserted patent, **USD852543S** (corrected application number: **US29/685,495**), is a design patent protecting the ornamental appearance of a product in the juvenile sleep/travel product category. Design patents, governed under 35 U.S.C. § 171, protect the unique visual characteristics of a manufactured article rather than its functional attributes.

  • US D852,543S — Ornamental design of an inflatable toddler travel bed.
🔍

Designing a similar product?

Check if your juvenile product design might infringe this or related patents before launch.

Run FTO Check →

The Verdict & Legal Analysis

Outcome

The case was resolved via **voluntary dismissal without prejudice**, filed by Keezio Group, LLC pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i). No damages were awarded. No injunctive relief was granted. The dismissal without prejudice preserves the plaintiff’s right to refile the same claims in the future, subject to applicable statutes of limitations and any potential Rule 11 considerations.

Key Legal Issues

The most analytically significant element of this case is the apparent mismatch between the **named defendant (Regeneron Pharmaceuticals, Inc.)** and the **party identified in the dismissal notice (Regalo International, LLC)**. This discrepancy highlights the critical importance of accurate defendant identification in patent assertion strategy. Such errors can expose plaintiffs to Fed. R. Civ. P. Rule 11 sanctions if not promptly corrected. The rapid dismissal suggests plaintiff’s counsel moved quickly once the issue was identified, before any responsive pleading was filed.

⚠️

Freedom to Operate (FTO) Analysis

This case highlights critical IP risks in consumer product design. Choose your next step:

📋 Understand This Case’s Impact

Learn about the specific risks and implications from this litigation.

  • View related patents in the juvenile products space
  • Analyze design patent claim scope against similar products
  • Understand procedural implications of voluntary dismissal
📊 View Patent Landscape
⚠️
High Risk Area

Accurate defendant identification is critical

📋
1 Patent at Issue

inflatable toddler travel bed design

Proactive FTO

recommended for consumer product designs

✅ Key Takeaways

For Patent Attorneys

Pre-answer voluntary dismissal under Rule 41(a)(1)(A)(i) requires no court approval but carries strategic costs, including potential refiling limitations and reputational considerations.

Search related case law →

Defendant identity verification is a non-negotiable element of pre-filing due diligence in any patent assertion, especially for PAEs.

Explore best practices →

Design patent infringement analysis under the ordinary observer test requires detailed prior art mapping before complaint filing.

Analyze design patent claims →
🔒
Unlock R&D Team Recommendations
Get actionable design patent strategy steps for product teams, including FTO timing guidance and documentation best practices.
FTO Timing Guidance Design-Around Strategies Documentation Best Practices
Explore Full Analysis in PatSnap Eureka

Frequently Asked Questions

Ready to Strengthen Your Patent Strategy?

Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.

PatSnap IP Intelligence Team

Patent Research & Competitive Intelligence · PatSnap

This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.

The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.

📊 2B+ Patent Data Points 🌍 120+ Countries Covered 🏢 18,000+ Customers Worldwide ⚖️ Global Litigation Database 🔍 Primary Source Verified

References

  1. USPTO Patent Center – USD852543S
  2. PACER Case Locator – 5:24-cv-00284
  3. Cornell Legal Information Institute — Federal Rule of Civil Procedure 41(a)(1)(A)(i)
  4. United States Court of Appeals for the Federal Circuit — Case Law Search
  5. PatSnap — IP Intelligence Solutions for Law Firms

This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.

⚖️ Disclaimer: This article is for informational purposes only and does not constitute legal advice. The analysis presented reflects publicly available case information and general legal principles. For specific advice regarding patent litigation, FTO analysis, or IP strategy, please consult a qualified patent attorney.